Search Results - Pfizer,

Pfizer Inks Up to $10.5 Billion Deal With China's Innovent.

Authors: Muller, Madison (AUTHOR)

Source: Bloomberg.com. 5/28/2026, pN.PAG-N.PAG. 1p.

Pfizer Tops Sales Estimates as Older Blockbusters Outperform.

Authors: Muller, Madison (AUTHOR)

Source: Bloomberg.com. 5/5/2026, pN.PAG-N.PAG. 1p.

MarketLine Company Profile: Pfizer Inc.

Source: Pfizer Inc. MarketLine Company Profile. 5/15/2026, p1-109. 109p.

Pfizer Bets on Weight-Loss Drugs to Power Its Next Decade.

Authors: Muller, Madison (AUTHOR)

Source: Bloomberg.com. 6/6/2026, pN.PAG-N.PAG. 1p.

Pfizer Advances Pneumonia Shot After Getting Positive Results in Children.

Authors: Muller, Madison (AUTHOR)

Source: Bloomberg.com. 5/20/2026, pN.PAG-N.PAG. 1p.

Pfizer Launches CFO Search as Denton Plans to Depart in August.

Authors: Cortez, Michelle Fay Muller, Madison

Source: Bloomberg.com. 6/18/2026, pN.PAG-N.PAG. 1p.

Pfizer Nabs China Obesity Drug Rights in $495 Million Deal.

Authors: Tong, Amber (AUTHOR)

Source: Bloomberg.com. 2/24/2026, pN.PAG-N.PAG. 1p.

Pfizer to Buy Metsera for $10 Billion, Capping Bidding War.

Authors: Langreth, Robert Davis, Michelle F. Sisco, Josh

Source: Bloomberg.com. 11/8/2025, pN.PAG-N.PAG. 1p.

Pfizer Boosts Profit Outlook as Battle for Obesity Startup Grows.

Authors: Muller, Madison (AUTHOR)

Source: Bloomberg.com. 11/4/2025, pN.PAG-N.PAG. 1p.

Pfizer to Buy Metsera for $10 Billion, Capping Bidding War.

Authors: Davis, Michelle F. Sisco, Josh Langreth, Robert

Source: Bloomberg.com. 11/14/2025, pN.PAG-N.PAG. 1p.

Pfizer Sweetens Its Offer for Metsera in Bidding War Against Novo.

Authors: Davis, Michelle F. Sisco, Josh

Source: Bloomberg.com. 11/7/2025, pN.PAG-N.PAG. 1p.

Pfizer Secures China Rights to Obesity Drug in $495 Million Deal.

Authors: Tong, Amber (AUTHOR)

Source: Bloomberg.com. 2/23/2026, pN.PAG-N.PAG. 1p.

Pfizer Releases New Obesity Data, Leaving Investors Wanting More.

Authors: Muller, Madison (AUTHOR)

Source: Bloomberg.com. 2/3/2026, pN.PAG-N.PAG. 1p.

Pfizer Ponders Viagra Lessons to Chart First Obesity Drug Launch.

Authors: Furlong, Ashleigh (AUTHOR)

Source: Bloomberg.com. 2/19/2026, pN.PAG-N.PAG. 1p.

Pfizer Drops as Drugmaker Predicts Little Sales Growth in 2026.

Authors: Muller, Madison Langreth, Robert

Source: Bloomberg.com. 12/16/2025, pN.PAG-N.PAG. 1p.

Pfizer Wins Obesity Drug Battle, With Assist by Trump's FTC.

Authors: Langreth, Robert Kresge, Naomi Davis, Michelle F. et al.

Source: Bloomberg.com. 11/10/2025, pN.PAG-N.PAG. 1p.

Pfizer Wins Obesity Drug Prize, With Trump Administration Assist.

Authors: Langreth, Robert Kresge, Naomi Davis, Michelle F. et al.

Source: Bloomberg.com. 11/10/2025, pN.PAG-N.PAG. 1p.

Pfizer Loses Legal Bid to Temporarily Block Novo's Metsera Offer.

Authors: Feeley, Jef (AUTHOR)

Source: Bloomberg.com. 11/5/2025, pN.PAG-N.PAG. 1p.

Pfizer Boosts Profit View As it Battles for Obesity Startup.

Authors: Muller, Madison (AUTHOR)

Source: Bloomberg.com. 11/4/2025, pN.PAG-N.PAG. 1p.

Pfizer CEO Sees CDC Director Pick Restoring Agency's Credibility.

Authors: Nix, Jessica Muller, Madison

Source: Bloomberg.com. 5/5/2026, pN.PAG-N.PAG. 1p.